The transgenic construct contains a mutated rat transforming growth factor, beta receptor II cDNA driven by the tetracycline operator (tetO). The Tgfbr2 cDNA contains a truncation mutation, resulting in a complete deletion of the transmembrane and intracellular domains. (J:114572)